The CNF1 toxin is produced by uropathogenic and meningitis-causing Escherichia coli. CNF1 penetrates autonomously into cells and confers phagocytic properties to epithelial and endothelial cells. CNF1 acts at the molecular level by constitutively activating Rho GTPases attenuated by their cellular ubiquitin-mediated proteasomal degradation. Here we report the relationship between the ubiquitin-mediated proteasomal degradation of activated Rho and the endothelial cell response to the toxin. The type of cellular response to CNF1 intoxication, first screened by DNA microarray analysis, revealed the launching of a program oriented toward an inflammatory response. Parallel to Rho protein activation by CNF1, we also established the kinetics of production of monocyte chemotactic protein-1 (MCP-1), interleukin-8 (IL-8), IL-6, monocyte inflammatory protein-3␣ (MIP-3␣) and E-selectin. Both the mutation of the catalytic domain of the toxin (CNF1-C866S) and the inhibition of Rho proteins abrogate the CNF1-induced production of the immunomodulators MIP-3␣, MCP-1, and IL-8. These immunomodulators are also produced upon activation of Cdc42 and Rac preferentially. Our results indicate that, in addition to pathogen molecular pattern recognition by host-receptors, a direct activation of Rho proteins by the CNF1 virulence factor efficiently triggers a cellular reaction of host alert. Consistently, we assume that the CNF1-induced ubiquitinmediated proteasomal degradation of activated Rho proteins may limit the amplitude of the host cell immune responses.
1 from pathogenic Escherichia coli, have all been documented to allow pathogenic bacteria internalization into host cells, despite their different molecular activities (1) (2) (3) .
Rho proteins are essential regulatory molecules, controlling the actin cytoskeleton organization and dynamic. They act to fine-tune the cell, reshaping it during cell polarity, movement, differentiation, and phagocytosis (4 -6) . In addition, they interfere with a variety of signaling pathways controlling gene transcription (7) . For instance, Rac and Cdc42 are activated downstream of the Toll-like receptor-2, implicated in Gram-positive pathogen-associated molecular pattern recognition (8, 9 ). Another example of the relationship between Rho proteins and the host defenses is the Rac/Cdc42-dependent formation of a supramolecular activation complex or "immunological synapse" crucial for lymphocyte activation (10) . In addition, both Rac1 and Rac2 are required for B-cell development and maintenance (11) .
An important contradiction to be clarified in host-pathogen interactions is the fact that Rho proteins are activated both by bacterial virulence factors and by host cell receptors engaged in pathogen recognition. In this respect, CNF1 toxin is a particularly suitable model. This bacterial toxin specifically deamidates glutamine 63 of RhoA (and its equivalent in Rac and Cdc42) into a glutamic acid (12) (13) (14) . This point mutation, catalyzed by CNF1, abrogates the GTPase activity of Rho proteins and produces their permanent activation. Once they are constitutively activated, Rho proteins are rapidly conveyed to the ubiquitin-mediated proteasomal degradation pathway (15, 16) . Thus CNF1 uses a seemingly counterintuitive mechanism, first constitutively activating Rho proteins (deamidation), so they are prone to inactivation (degradation). This mechanism results in a moderate activation of Rho proteins and confers highly invasive properties to CNF1-producing uropathogenic E. coli and meningitis K1 E. coli (15, 17) . Such tight control of the level of activated Rho proteins is found in other invasive systems. These have been characterized in Salmonella, which co-inject SopE for Rac and Cdc42 activation and SptP for Rac and Cdc42 inactivation (18) . As compared with invasive factors injected upon bacterial contact with host cell target, CNF1 shares with the A-B toxins the ability to enter host cells independently of other bacterial factors (1) . In the present study we took advantage of the toxic properties of CNF1 to investigate the cellular responses it elicits, independently of the productive bacteria.
EXPERIMENTAL PROCEDURES
Cells and Reagents-Human umbilical vein endothelial cells (HUVECs) were obtained from PromoCell (Heidelberg, Germany). Cells were grown in human endothelial SFM medium (Invitrogen) supplemented with defined growth factors (d-SFM): 10 ng/ml epidermal growth factor and 20 ng/ml basic fibroblast growth factor (Invitrogen), 1 g/ml heparin (Sigma-Aldrich), and either 20% fetal bovine serum (Invitrogen) or 1% (w/v) bovine serum albumin (ELISA grade, SigmaAldrich) together with penicillin and streptomycin (Invitrogen). Cells were grown on 0.2% gelatin-coated dishes (Sigma-Aldrich). Transfections of HUVECs were carried out as previously described (19) . Antibodies used were monoclonal anti-␤-actin antibody (clone AC-74, Sigma-Aldrich); anti-RhoA, anti-Cdc42, anti-Rac1, and anti-Ras antibodies (BD Transduction Laboratories); anti-HA (clone 11, BabCO); anti-Eselectin (clone CTB202, Santa Cruz Biotechnology); rabbit polyclonal anti-phospho-p44/42 MAP kinase (Thr 202 /Tyr 204 ), anti-phospsho-p38 MAP kinase (Thr 180 /Tyr 182 ), and anti-phospho-c-Jun (Ser 73 , Cell Signaling Technology); anti-human IB␣ (Upstate Biotechnology); and anti-TRAF1 (H-186, Santa Cruz Biotechnology). Primary antibodies were visualized using goat anti-mouse or anti-rabbit horseradish peroxidase-conjugated secondary antibodies (DAKO, Glostrup, Denmark). TRAF1 rabbit antibodies were visualized using biotin-XX goat antirabbit IgG followed by streptavidin horseradish peroxidase conjugate (Molecular Probes). DNA vectors corresponding to pcDNA3RhoQ63L, RacQ61L, and Cdc42Q61L were provided by Manor, D (20) .
DNA Array Analysis-CNF1-regulated genes were analyzed by Aros Applied Biotechnology ApS (www.arosab.com), using the Affymetrix technology (21) and Affymetrix® Human GeneChip U133A and U133B, as recommended by the manufacturer (www.Affymetrix.com). HUVECs were seeded at 8 ϫ 10 6 cells/150-mm gelatin-coated dish in d-SFM containing BSA. HUVECs were intoxicated in parallel for 3 and 24 h in d-SFM/BSA supplemented with 10 Ϫ9 M CNF1. HUVECs were lysed in RTL buffer for RNA extraction by RNeasy MiniKit (Qiagen, Valencia, CA). Both integrity and purity of RNA were checked using the Bioanalyzer 2100 and RNA 6000 LabChip kit from Agilent Technologies (Palo Alto, CA). Total RNA (5 g) was used as starting material for the cDNA preparation. The first and second strand cDNA synthesis was performed using the SuperScript II System (Invitrogen) according to the manufacturer's instructions except using an oligo(dT) primer containing a T7 RNA polymerase promoter site. Labeled cRNA was prepared using the BioArray High Yield RNA Transcript Labeling Kit (Enzo Biochem, New York, NY). Biotin-labeled CTP and UTP (Enzo) were used in the reaction together with unlabeled NTPs. Following the in vitro transcription reaction, the unincorporated nucleotides were removed using RNeasy columns (Qiagen). cRNA (15 g ) was fragmented at 94°C for 35 min in a fragmentation buffer containing 40 mM Tris acetate, pH 8.1, 100 mM KOAc, 30 mM MgOAc. Prior to hybridization, the fragmented cRNA in a 6ϫ SSPE-T hybridization buffer (1 M NaCl, 10 mM Tris, pH 7.6, 0.005% Triton) was heated to 95°C for 5 min and subsequently to 45°C for 5 min before loading onto the Affymetrix HG_U133A and U133B probe array cartridges. The probe array was then incubated for 16 h at 45°C at constant rotation (60 rpm). The washing and staining procedure was performed in the Affymetrix Fluidics Station 400. The probe array was exposed to 10 washes in 6ϫ SSPE-T at 25°C followed by four washes in 0.5ϫ SSPE-T at 50°C. The biotinylated cRNA was stained with a streptavidin-phycoerythrin conjugate, at a final concentration a 2 mg/ml (Molecular Probes, Eugene, OR) in 6ϫ SSPE-T for 30 min at 25°C followed by 10 washes in 6ϫ SSPE-T at 25°C. An antibody amplification step followed using normal goat IgG as blocking reagent, at a final concentration of 0.1 mg/ml (Sigma), and biotinylated anti-streptavidin antibody (goat), at a final concentration of 3 mg/ml (Vector Laboratories). This was followed by a staining step with a streptavidin-phycoerythrin conjugate, at a final concentration of 2 mg/ml (Molecular Probes) in 6ϫ SSPE-T for 30 min at 25°C, and 10 washes in 6ϫ SSPE-T at 25°C. The probe arrays were scanned at 560 nm using a confocal laser scanning microscope (Hewlett Packard GeneArray Scanner G2500A). The readings from the quantitative scanning were analyzed by the Affymetrix Gene Expression Analysis Software 5.0 (MAS 5.0) (22) . Data from the individual samples were subjected to pairwise comparison analyses in the Software MAS 5.0, based on empirical algorithms as described by the manufacturer on their web site (www.affymetrix.com/support/technical/technotes/statistical_ reference_guide.pdf). Briefly, the Change Algorithm indicated a change in transcript level between a baseline and an experiment array, further indicating an increase, marginal increase, decrease, marginal decrease, or no change in gene expression. On the other hand, the Signal Log Ratio Algorithm estimated the magnitude and direction of change of a transcript when two arrays were compared (experiment versus baseline), expressed as the log 2 ratio. In our analysis, these algorithms allowed the comparison between two samples, the one used as baseline being the non-intoxicated cells, and the experiment being the cells intoxicated by CNF1 for 3 or 24 h. This analysis of gene expression reported by the Affymetrix software in paired experiments indicated whether a statistically significant change in expression had occurred. We considered that a gene was significantly induced or repressed when the Signal Log Ratio was Ն2 or ՅϪ2, respectively. Ϫ9 M CNF1 for different periods of time. Cell lysates were subjected to GST fusion protein pull-down assays (denoted as GTPases with "-GTP"). In parallel, 2% of each cell lysate was processed for immunoblotting to monitor GTPases cellular depletion (denoted as GTPases with "Total-"). B, quantification of the CNF1-induced Rho protein activation. Immunoblots were scanned and quantified using Image 1.63 (National Institutes of Health). The level of activated Rho proteins was compared with the total Rho GTPase level present in 2% of control cell lysates (mean value of three independent experiments Ϯ S.D.). C, immunoblots illustrating the interference of CNF1 on cell signaling pathways. HUVECs were treated with 10 Ϫ9 M CNF1 for the indicated periods of time, prior to immunoblotting analysis. MAP kinase signaling was investigated using anti-phospho-p44/42 MAP kinase (P-p44/42) and anti-phosphop38 MAP kinase (P-p38) antibodies. Jun kinase activity was investigated by anti-phospho-c-Jun (P-c-jun) immunoblotting. NFB signaling pathway activation was investigated by following the IB␣ cellular depletion on immunoblots.
Toxins-For recombinant CNF1 and CNF1-C866S toxin purification, E. coli OneShot bacteria, carrying pCR2cnf1 or pCR2cnf1C866S, were grown overnight at 37°C in LB medium. Bacteria were harvested by centrifugation, suspended in 30 ml of phosphate-buffered saline, and lysed using a French press. The lysate was centrifuged (30,000 ϫ g for 30 min, at 4°C), and the supernatant was precipitated with the same volume of saturated ammonium sulfate for 5-8 h. The precipitate was then dialyzed against TN buffer (25 mM Tris (pH 7.4), 50 mM NaCl) and applied on a DEAE fast flow column (11 ϫ 1.5 cm, Amersham Biosciences). The column was washed for 200 min with the same buffer (1 ml/min). CNF1 was eluted with a 50 to 300 mM NaCl gradient during 100 min (elution around 200 mM NaCl). The fractions containing CNF1 were pooled, dialyzed against TN buffer, and applied on a Superdex 75 column (0.3 ml/min, Amersham Biosciences). The fractions containing CNF1 were pooled, concentrated, and applied on a Mono Q column (Amersham Biosciences). After a 20-min wash (1 ml/min) of the column with TN buffer, CNF1 was eluted using a 50 to 400 mM NaCl gradient (elution around 350 mM NaCl). CNF1 purification process was checked by SDS-PAGE. The activity of the different batches of CNF1 toxin was estimated by using an HEp-2 cell multinucleation assay previously described (23) . The purified CNF1 toxin used in this study produced at 10 Ϫ12 M 50% of multinucleation of HEp-2 cells after 48 h of intoxication (Supplemental Fig. 2 ). After purification, the cell binding activity of the catalytic inactive toxin CNF1-C866S was estimated by measuring its competing effects on the CNF1-induced multinucleation of HEp-2 cells (Supplemental Fig. 2) .
ELISA-HUVECs were seeded 24 h before toxin addition at 2 ϫ 10 Pull-down and Immunoblotting-Activated Rho, Rac, and Cdc42 GST-protein pull-down experiments were performed as described in Ref. 15 . For activated Ras measurements we made use of GST-RBD of Raf1 as described by the authors (24) . Proteins were resolved on 12% SDS-PAGE, transferred onto polyvinylidene difluoride membranes, and immunoblotted, and then chemiluminescence detection was carried out (Amersham Biosciences).
RESULTS

Activation of Rho GTPases by CNF1 Interferes with Host Cell
Signaling Pathways-The molecular mechanism of action of CNF1 is dual. It consists of a permanent activation of Rho proteins, which results in their sensitization to ubiquitin-mediated proteasomal degradation (12, 13, 15, 16) . We have previously established that this dual mechanism of action confers higher invasive properties to pathogenic bacteria (15) . Considering that activated Rho proteins might interfere with cellular programs of transcription, we further investigated the relation- Table I . Note that, except for Gro␥ and CSF2, all other genes were found induced at both 3 and 24 h of cell treatment with the toxin. ship between the host response and the CNF1-induced Rho protein activation (deamidation) and deactivation (proteasomal degradation). We thus first screened the host cell genetic program elicited by CNF1 in primary human endothelial cells (HUVECs) using conditions of maximal activation of Rho proteins. We assumed that, in addition, this approach should inform us of the type of cellular response engaged by Rho protein activation. HUVECs represent a relevant cellular system for meningitis-causing E. coli K1, producing CNF1 (17) . In addition, HUVECs have the advantage of being primary cells, an important aspect in conducting signal transduction studies. Kinetics of CNF1-induced Rac1, Cdc42, and RhoA activation were first established (Fig. 1A) . Activation of the Rho protein family appeared specific, as compared with the Ras GTPase. These measurements do not represent an exhaustive list of the Rho proteins activated by CNF1, because other Rho members are known to bear the canonical sequence for CNF1 recognition/modification (14) . Nevertheless, these measurements indicate that all the three Rho proteins exhibit a maximal activation about 2 h after exposure to CNF1 (Fig. 1B) . The interference of CNF1 with classic signaling pathways leading to gene regulation was next investigated. Consistent with the absence of Ras activation, CNF1 did not produce ERK1/2 phosphorylation (Fig. 1, A and C) . Rather, CNF1 appeared to interfere with the stress-activated protein kinase signaling pathways, unraveled by p38 MAPK and c-Jun phosphorylation (Fig.  1C) . CNF1 also interfered with the NFB pathway, as indicated by IB-␣ depletion (Fig. 1C) . Having established that CNF1 modulates gene-signaling pathways prompted us to determine the type of endothelial cell response elicited by CNF1 intoxication.
Transcriptome of Primary Endothelial Cells Intoxicated by CNF1-
The effect of CNF1 on gene regulation was screened both at 3-and 24-h intervals after the addition of the toxin, using U133A and U133B Affymetrix® microarrays. These arrays resulted in a large screen of the activity of about 33,000 human genes. CNF1 triggers a gene response consisting of a selective activation of only 0.19% and 0.08% of the genes probed at 3 and 24 h, respectively ( Fig. 2A and Table I ). Only 0.04% and 0.03% of the genes probed were found to be inhibited at 3 and 24 h of CNF1 exposure, respectively, although at low levels ( Fig. 2A and Table II) . A majority of genes was found induced at a higher level after 3 h (as compared with 24 h) of CNF1 exposure, thereby following the kinetics of Rho protein activation by the toxin (Figs. 1B and 2A) . No clear functions could be assigned to genetic programs either engaged specifically at 24 h or corresponding to down-regulated genes. In contrast, we observed that the 10 most activated genes formed a coherent family of inflammatory mediators, aimed at leukocyte recruitment and activation ( Fig. 2B and Table I ) (25) . Induction of inflammatory chemokine-encoding genes could be correlated to the induction of the leukocyte cell-binding receptors E-selectin and ICAM-1. Cell response to CNF1 also includes MIP-3␣/CCL20, a chemokine of dendritic cells (Fig. 2B ) (26). Finally, TRAF1 (TNF-receptor associated protein-1) and cIAP2 (mammalian inhibitor of apoptosis protein-1 homologue C) were assigned in impairing TNF-␣ receptor cell death signaling ( Fig. 2B and Table I ) (27) . This screen orientated us in studying the specificity of the production of a representative set of inflammatory mediators toward the CNF1 activity and Rho protein activation. We reasoned that, in addition to shedding light on the CNF1 mechanism of action, this should establish whether this list might represent putative Rho-regulated genes in endothelial cells. Specificity of Inflammatory Mediator Production-We first established the kinetics of production of MIP-3␣ and IL-6, the highest and the lowest immunomodulator (IM)-induced genes, respectively (Table I and Fig. 3A) . Specificity of IM production was established by comparing the effects of CNF1 to those of the catalytically inactive mutant CNF1-C866S, which was found to be devoid of interference with probed signaling pathways (Supplemental Fig. 1) . Production of IM started between 2 and 4 h after addition of toxin, reaching a maximal level 6 h after intoxication that was sustained for 24 h (Fig. 3A) . The kinetics of IL-8 and MCP-1 production gave similar profiles (Fig. 3A) . In addition, we verified the specificity of production of E-selectin and TRAF1, in response to CNF1 intoxication (Fig.  3, B and C) . Finally, consistent with the DNA microarray analysis, we did not detect a CNF1-induced production of RANTES and TNF-␣ at the protein level (not shown). In conclusion, we have shown that HUVECs respond specifically to the native CNF1 toxin by producing E-selectin, MCP-1, MIP-3␣, IL-8, IL-6 immunomodulators, as well as TRAF1.
Activated Rac1 and Cdc42 but Not RhoA Trigger Inflammatory Mediator Production-We further addressed the question of the specificity of the Rho protein activation by CNF1 for MCP-1, MIP-3␣, IL-8, and IL-6 production. We first made use of toxin B from Clostridium difficile for its inactivating properties toward Rho proteins (28) . When HUVECs were pretreated with different doses of toxin B prior to CNF1 exposure, we observed that toxin B could eliminate the CNF1-induced production of MCP-1, MIP-3␣, IL-8, and IL-6, in a dose-dependent manner (see Fig. 5A ). These results suggested that the activation of Rho proteins by CNF1 is required at least for the production of all four IMs by HUVECs. This prompted us to investigate the role of RhoA, Rac1, and Cdc42 for IM production. Transient expression of each activated Rho protein was carried out in HUVECs. Equal expression of activated Rho proteins was verified by anti-HA immunoblotting (Fig. 5B) . We observed production of MCP-1, MIP-3␣, and IL-8, whereas induction of IL-6 could not be detected in these experimental conditions, consistent with the low level of its induction by CNF1 (Fig. 5B) . Expression of activated Cdc42 or activated Rac1 was sufficient to trigger the induction of all the three IMs. Activated RhoA did not elicit significant amounts of these IMs, thereby emphasizing Cdc42 and Rac1 specificity for MCP-1, MIP-3␣, and IL-8 production, in HUVECs. These results are consistent with our measurements of the degree to which CNF1 activates Rho GTPases in HUVECs, with a maximal activation of Cdc42 and Rac (Fig. 1B) .
Relationship between Proteasomal Degradation of Activated Rac and Inflammatory Mediator Production-Induction of Rac and/or Cdc42 by CNF1 resulted in the production of a large variety of inflammatory mediators, maximal for MCP-1. These results raised the apparent contradiction of CNF1 as a bacterial virulence factor being responsible for triggering the recruitment of leukocytes immune effectors. We thus further addressed the relationship between the CNF1 molecular mechanism of action, consisting of Rac activation followed by proteasomal degradation to the extent of MCP-1 induction. We first established the CNF1-induced production of MCP-1 using different concentrations of toxin. MCP-1 production was measured at 6 h of intoxication by CNF1, corresponding to the toxin maximal effects previously determined (Fig. 3A) . This showed an increase of MCP-1 production for cells treated with higher concentrations of toxin (Fig. 5A) . Levels of MCP-1 production were then compared with the corresponding levels of CNF1-induced activated Rac. Quantities of MCP-1 produced were found to correlate with the extent of activation of Rac triggered by CNF1 (Fig. 5B) . These results were also consistent with our findings showing that higher levels of activated Rac expression resulted in an increase of MCP1 production (Fig. 4B) . Given the direct relationship between levels of activated Rac and the resulting levels of MCP-1 produced, we next examined the effects of proteasome inhibition toward the CNF1-induced activation of Rac. At 6 h, using CNF1 as low as 10 Ϫ11 M, we observed an increase in the levels of activated Rac in cells co-treated with the proteasome inhibitor MG132 (Fig. 5B) . This most probably resulted from the accumulation of non-degraded forms of activated Rac. Taken together, these results indicate that the cellular inflammatory response resulting from the CNF1-induced activation of Rac may be limited by the proteasomalmediated degradation of activated Rac.
DISCUSSION
In the present study, we have addressed the question of whether a relationship exists between the level of Rho protein activation by CNF1 and its consequence toward a possible host cell response. As a first approach, we performed a large screen of the CNF1-regulated genes, using Affymetrix microarrays. We choose to document the host cell response at two different time points rather than twice at the same time point to document a possible correlation between the levels of activated Rho proteins and the extent of regulation of the target gene screened. Most of the CNF1-regulated genes were found upregulated at both time points. Hence, some CNF1 up-regulated genes were fully confirmed at the protein level and found produced in response to activated Rac or Cdc42 expression. Taken together, our results suggest that the genes described in Table I represent a list of putative Rho-regulated genes.
The cellular response to CNF1 intoxication includes a large panel of inflammatory effectors responsible for leukocyte recruitment, cell binding, and activation. Leukocyte arrival to the site of infection also requires additional regulators comprising membrane metalloproteases and syndecan family products, the gene family members of which appear to be induced by CNF1 (Ref. 29 and Table I ). Other identified inflammatory regulators such as plasminogen activator urokinase (for lumen arteries restriction) as well as prostaglandin G/H synthesis enzymes may complete the task of leukocyte recruitment and activation to the site of bacterial infection. In agreement with the idea that CNF1-intoxicated cells produce a response against pathogen, we observed the induction of genes coding for innate- defense effectors, comprising complement factor-3 for pathogen phagocytosis and factor-9 (a component of the cytolytic membrane attack complex), as well as GliPR, a plant pathogen-1-related protein homologue (30, 31) . In that respect MIP-3␣, in addition to being a chemokine for dendritic cells, has been suggested to have a defensin-like activity (26, 32) . In addition to an immediate inflammatory response, endothelial cells probably produce an amplification loop for organizing an adapted immune response (33) . Production of GRO family and MIP-3␣ chemokines may participate in recruiting lymphocytes and antigen-presenting dendritic cells, respectively (25, 26) . This amplification loop might then be completed by IL-6 release for inhibition of regulatory T cells (34) . Finally, the transcriptome of CNF1-intoxicated HUVECs appears to share many similarities with known TNF␣-regulated genes, among them TRAF1, cIAP2, and A20, whose gene products confer a protection against cell death receptor-induced apoptosis (27) . This raises the question as to whether the induction of extrinsic and intrinsic apoptosis inhibitors during acute inflammation may favor the sheltering of cell-internalized bacteria.
One interesting aspect of the inflammatory mediator production induced by CNF1 is that it could be abrogated by Rho protein inhibition. Complementary to this observation, we demonstrated that MIP-3␣, MCP-1, and IL-8 were produced upon cellular expression of activated Cdc42 or activated Rac1 but not activated RhoA. In parallel, we have observed that inhibition of RhoA, using C3-exoenzyme, had no inhibitory effects on the CNF1-induced secretion of this group of inflammatory mediators (not shown). Taken together, our results thus point to Cdc42 and Rac as major mediators of the host transcriptome elicited by CNF1, therefore constituting a list of potential Cdc42-and/or Rac-regulated genes, in the absence of concurrent signals. This hypothesis is strengthened by the GeneCalling analysis of the genetic program engaged upon HUVECs binding to fibronectin, a matrix protein, which produces the activation of Rac (19, 35) . In these conditions, cells induced a similar pattern to that of CNF1, comprising E-selectin, ICAM-1, vascular cell adhesion molecule-1, Syndecan-4, IL-8, Gro␣, Gro␤, A20, TRAF1, and cIAP2 (35) . Both studies illustrate that Cdc42/Rac activation, either by fibronectin for angiogenesis or by CNF1, engaged similar genetic programs in HUVECs. It is likely that the common denominator of both input signals represents a cellular response to stress for tissues healing and/or pathogen clearing. In conclusion, Cdc42 and Rac, in addition to being effectors of the cellular response against pathogens, are probably central elements of the cellular perception of loss of homeostasis.
A key question in host-pathogen interaction studies is now addressed by both findings that some bacterial virulence factors can activate Rac/Cdc42 and that these Rho proteins are key elements of the host defenses against pathogens (1). Our approach is complementary to studies that sought to document the specificity of the genetic programming engaged in host-cell interaction with other invasive Gram-negative bacteria (36, 37) . All these studies concur in establishing that similar groups of inflammatory mediators are induced in response to invasive systems evolved by Gram-negative bacteria. For instance, consistent with this idea, host cells respond similarly to CNF1 intoxication and invasive Shigella infection by producing specifically granulocyte macrophage-colony stimulating factor, IL-8, CCL20/MIP-3␣, CXCL-1/Gro␣, CXCL-2/Gro␤, CXCL-3/ Gro␥, and ICAM-1 (36) . In addition, our results show a direct relationship between the extent of Rho protein activation and the amplitude of the host alarm response by intoxicated cells. Considering this, it is likely that bacteria have evolved virulence systems aiming at producing a moderate activation of Rho proteins to delay and/or depress the cellular alarm program of the host while invading cells. Such a moderate activation of Rho proteins, resulting from the combined activation and inactivation of Rho proteins by invasive factors, may be beneficial during early stages of a bacterial infection, prior substantive bacterial growth and a resulting inflammatory reaction. These ideas are in agreement with the development of an infection by uropathogenic E. coli, which results in an inflammatory disease. In that respect, the mechanism of action of CNF1 consisting of Rho protein activation (deamidation) and deactivation (ubiquitin-mediated proteasomal degradation) appears sharply adapted in producing a moderate activation of Rho proteins.
